| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA2 BCL9L PARP10 NCOR1 ARID1B AEBP2 NCOA1 SRCAP CREBBP MAML3 EP300 KDM1A | 8.98e-08 | 562 | 60 | 12 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.84e-07 | 303 | 60 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 4.21e-07 | 417 | 60 | 10 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA2 PARP10 NCOR1 NCOA1 ISL1 KEAP1 FOXA1 CREBBP TRIB1 EP300 KDM1A | 1.10e-06 | 582 | 60 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA2 BCL9L PARP10 NCOR1 ARID1B SH3RF1 FBXO42 AEBP2 NCOA1 KEAP1 SRCAP CREBBP MAML3 EP300 KDM1A | 1.19e-06 | 1160 | 60 | 15 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA2 GPHN BCL9L PARP10 NCOR1 ARID1B SH3RF1 FBXO42 AEBP2 NCOA1 KEAP1 SRCAP CREBBP MAML3 EP300 KDM1A | 1.61e-06 | 1356 | 60 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 3.69e-06 | 78 | 60 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 4.52e-06 | 37 | 60 | 4 | GO:0043425 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 8.88e-06 | 2 | 60 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 8.88e-06 | 2 | 60 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA2 PARP10 NCOR1 NCOA1 ISL1 KEAP1 FOXA1 CREBBP TRIB1 EP300 KDM1A | 1.29e-05 | 753 | 60 | 11 | GO:0008134 |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 1.38e-05 | 102 | 60 | 5 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 1.51e-05 | 104 | 60 | 5 | GO:0016407 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.66e-05 | 51 | 60 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 1.93e-05 | 53 | 60 | 4 | GO:0030331 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 2.05e-05 | 187 | 60 | 6 | GO:0016922 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 2.24e-05 | 55 | 60 | 4 | GO:0061733 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 2.66e-05 | 3 | 60 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 3.17e-05 | 60 | 60 | 4 | GO:0034212 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 3.30e-05 | 21 | 60 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 4.38e-05 | 23 | 60 | 3 | GO:0046965 | |
| GeneOntologyMolecularFunction | histone modifying activity | 6.36e-05 | 229 | 60 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | MRF binding | 1.32e-04 | 6 | 60 | 2 | GO:0043426 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.38e-04 | 739 | 60 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 6.05e-04 | 55 | 60 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 7.39e-04 | 238 | 60 | 5 | GO:0016747 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 8.20e-04 | 61 | 60 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 9.09e-04 | 15 | 60 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NCOA2 NCOR1 ZNF148 EBF3 ZSCAN4 NCOA1 ISL1 FOXA1 RFX1 CREBBP EP300 KDM1A | 1.16e-03 | 1459 | 60 | 12 | GO:0000977 |
| GeneOntologyMolecularFunction | p53 binding | 1.61e-03 | 77 | 60 | 3 | GO:0002039 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 1.63e-03 | 20 | 60 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 1.97e-03 | 22 | 60 | 2 | GO:0050321 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 2.00e-03 | 83 | 60 | 3 | GO:1990841 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 4.42e-03 | 33 | 60 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 4.48e-03 | 875 | 60 | 8 | GO:0019904 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 4.68e-03 | 34 | 60 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | lncRNA binding | 4.96e-03 | 35 | 60 | 2 | GO:0106222 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 4.97e-03 | 229 | 60 | 4 | GO:0003714 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 6.13e-03 | 39 | 60 | 2 | GO:0097718 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 6.75e-03 | 938 | 60 | 8 | GO:0016772 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 8.35e-03 | 775 | 60 | 7 | GO:0016746 | |
| GeneOntologyMolecularFunction | tau protein binding | 8.44e-03 | 46 | 60 | 2 | GO:0048156 | |
| GeneOntologyBiologicalProcess | cellular response to Thyroglobulin triiodothyronine | 9.82e-08 | 4 | 61 | 3 | GO:1904017 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 2.18e-07 | 87 | 61 | 6 | GO:0033143 | |
| GeneOntologyBiologicalProcess | response to Thyroglobulin triiodothyronine | 4.89e-07 | 6 | 61 | 3 | GO:1904016 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 2.17e-06 | 202 | 61 | 7 | GO:0141193 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 3.03e-06 | 136 | 61 | 6 | GO:0030518 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 3.47e-06 | 416 | 61 | 9 | GO:0030522 | |
| GeneOntologyBiologicalProcess | regulation of DNA-binding transcription factor activity | 6.44e-06 | 449 | 61 | 9 | GO:0051090 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 6.45e-06 | 155 | 61 | 6 | GO:0043401 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 7.53e-06 | 244 | 61 | 7 | GO:0009755 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 1.58e-05 | 381 | 61 | 8 | GO:0048545 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | CPEB2 NCOA2 CLDN18 NCOR1 ARID1B NCOA1 ISL1 FOXA1 EP300 KDM1A | 4.93e-05 | 727 | 61 | 10 | GO:0032870 |
| GeneOntologyBiologicalProcess | positive regulation of female receptivity | 5.14e-05 | 4 | 61 | 2 | GO:0045925 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 5.14e-05 | 4 | 61 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | chromatin organization | PARP10 NCOR1 ARID1B RPS6KA4 AEBP2 NCOA1 SRCAP FOXA1 CREBBP EP300 KDM1A | 5.58e-05 | 896 | 61 | 11 | GO:0006325 |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 7.41e-05 | 239 | 61 | 6 | GO:0071383 | |
| GeneOntologyBiologicalProcess | regulation of androgen receptor signaling pathway | 1.04e-04 | 31 | 61 | 3 | GO:0060765 | |
| GeneOntologyBiologicalProcess | diencephalon development | 1.46e-04 | 90 | 61 | 4 | GO:0021536 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | PARP10 NCOR1 ARID1B RPS6KA4 AEBP2 NCOA1 SRCAP FOXA1 CREBBP EP300 KDM1A | 1.47e-04 | 999 | 61 | 11 | GO:0071824 |
| GeneOntologyBiologicalProcess | positive regulation of hydrogen peroxide-mediated programmed cell death | 1.79e-04 | 7 | 61 | 2 | GO:1901300 | |
| GeneOntologyBiologicalProcess | response to hormone | CPEB2 NCOA2 CLDN18 NCOR1 ARID1B SH3RF1 NCOA1 ISL1 FOXA1 EP300 KDM1A | 2.12e-04 | 1042 | 61 | 11 | GO:0009725 |
| GeneOntologyBiologicalProcess | regulation of thyroid hormone receptor signaling pathway | 2.38e-04 | 8 | 61 | 2 | GO:0002155 | |
| GeneOntologyBiologicalProcess | regulation of female receptivity | 3.06e-04 | 9 | 61 | 2 | GO:0045924 | |
| GeneOntologyBiologicalProcess | thyroid hormone receptor signaling pathway | 3.06e-04 | 9 | 61 | 2 | GO:0002154 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | 3.62e-04 | 598 | 61 | 8 | GO:0080135 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 4.63e-04 | 51 | 61 | 3 | GO:0030521 | |
| GeneOntologyBiologicalProcess | positive regulation of proteasomal protein catabolic process | 4.83e-04 | 123 | 61 | 4 | GO:1901800 | |
| GeneOntologyBiologicalProcess | connective tissue development | 5.21e-04 | 343 | 61 | 6 | GO:0061448 | |
| GeneOntologyBiologicalProcess | female mating behavior | 5.57e-04 | 12 | 61 | 2 | GO:0060180 | |
| GeneOntologyBiologicalProcess | regulation of epithelial to mesenchymal transition | 5.95e-04 | 130 | 61 | 4 | GO:0010717 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA2 BCL9L RPS6KA4 ZNF148 EBF3 NCOA1 ISL1 FOXA1 CREBBP MAML3 EP300 KDM1A | 6.65e-04 | 1390 | 61 | 12 | GO:0045944 |
| GeneOntologyCellularComponent | chromatin | NCOA2 NCOR1 ARID1B EBF3 AEBP2 ADNP2 NCOA1 ISL1 SRCAP FOXA1 RFX1 CREBBP EP300 KDM1A | 5.90e-05 | 1480 | 60 | 14 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | 2.89e-04 | 596 | 60 | 8 | GO:0005667 | |
| HumanPheno | Pilomatrixoma | 4.28e-06 | 9 | 20 | 3 | HP:0030434 | |
| HumanPheno | Abnormal lateral ventricle morphology | 6.80e-06 | 129 | 20 | 6 | HP:0030047 | |
| HumanPheno | Spina bifida occulta | 8.99e-06 | 77 | 20 | 5 | HP:0003298 | |
| HumanPheno | Plantar crease between first and second toes | 1.46e-05 | 2 | 20 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 1.46e-05 | 2 | 20 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 1.46e-05 | 2 | 20 | 2 | HP:0001042 | |
| HumanPheno | Social and occupational deterioration | 2.29e-05 | 15 | 20 | 3 | HP:0007086 | |
| HumanPheno | Prominent fingertip pads | 2.54e-05 | 46 | 20 | 4 | HP:0001212 | |
| HumanPheno | Abnormal columella morphology | 2.79e-05 | 97 | 20 | 5 | HP:0009929 | |
| HumanPheno | Prominent digit pad | 3.01e-05 | 48 | 20 | 4 | HP:0011298 | |
| HumanPheno | Skin appendage neoplasm | 4.07e-05 | 18 | 20 | 3 | HP:0012842 | |
| HumanPheno | Laryngeal cartilage malformation | 4.38e-05 | 3 | 20 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 4.38e-05 | 3 | 20 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 4.38e-05 | 3 | 20 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 4.38e-05 | 3 | 20 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 4.38e-05 | 3 | 20 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 4.38e-05 | 3 | 20 | 2 | HP:0005895 | |
| HumanPheno | Dislocated radial head | 4.82e-05 | 54 | 20 | 4 | HP:0003083 | |
| HumanPheno | Low hanging columella | 5.57e-05 | 56 | 20 | 4 | HP:0009765 | |
| HumanPheno | Abnormality of the radial head | 5.98e-05 | 57 | 20 | 4 | HP:0003995 | |
| HumanPheno | Abnormal nasal septum morphology | 6.36e-05 | 115 | 20 | 5 | HP:0000419 | |
| HumanPheno | Localized hirsutism | 6.58e-05 | 21 | 20 | 3 | HP:0009889 | |
| HumanPheno | Deep plantar creases | 6.58e-05 | 21 | 20 | 3 | HP:0001869 | |
| HumanPheno | Congenital malformation of the great arteries | 7.71e-05 | 529 | 20 | 9 | HP:0011603 | |
| HumanPheno | Abnormality of the hairline | 8.02e-05 | 294 | 20 | 7 | HP:0009553 | |
| HumanPheno | Abnormality of the humeroradial joint | 8.33e-05 | 62 | 20 | 4 | HP:0100744 | |
| HumanPheno | Trichiasis | 8.75e-05 | 4 | 20 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 8.75e-05 | 4 | 20 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 8.75e-05 | 4 | 20 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 8.75e-05 | 4 | 20 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 8.75e-05 | 4 | 20 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 8.75e-05 | 4 | 20 | 2 | HP:0031207 | |
| HumanPheno | Abnormal fingertip morphology | 9.03e-05 | 203 | 20 | 6 | HP:0001211 | |
| HumanPheno | Facial hypertrichosis | 9.80e-05 | 206 | 20 | 6 | HP:0002219 | |
| HumanPheno | Delayed ability to walk | 9.93e-05 | 304 | 20 | 7 | HP:0031936 | |
| HumanPheno | Short thumb | 1.02e-04 | 127 | 20 | 5 | HP:0009778 | |
| HumanPheno | Long eyelashes | 1.10e-04 | 129 | 20 | 5 | HP:0000527 | |
| HumanPheno | Abnormality of the frontal hairline | 1.24e-04 | 215 | 20 | 6 | HP:0000599 | |
| HumanPheno | Minor feet anomalies | 1.27e-04 | 26 | 20 | 3 | HP:0010613 | |
| HumanPheno | Abnormal feet morphology | 1.27e-04 | 26 | 20 | 3 | HP:0010611 | |
| HumanPheno | Hirsutism | 1.28e-04 | 216 | 20 | 6 | HP:0001007 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 1.45e-04 | 5 | 20 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 1.45e-04 | 5 | 20 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 1.45e-04 | 5 | 20 | 2 | HP:0030421 | |
| HumanPheno | Congenital abnormal hair pattern | 1.58e-04 | 327 | 20 | 7 | HP:0011361 | |
| HumanPheno | Abnormal morphology of the great vessels | ARID1B ZNF148 EBF3 KCNH1 TAOK1 SIK3 SRCAP CREBBP EP300 DNAH1 | 1.74e-04 | 736 | 20 | 10 | HP:0030962 |
| HumanPheno | Deep philtrum | 1.76e-04 | 75 | 20 | 4 | HP:0002002 | |
| HumanPheno | Short columella | 1.77e-04 | 29 | 20 | 3 | HP:0002000 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 1.96e-04 | 30 | 20 | 3 | HP:0005743 | |
| HumanPheno | Abnormal epididymis morphology | 1.96e-04 | 30 | 20 | 3 | HP:0009714 | |
| HumanPheno | Large foramen magnum | 2.18e-04 | 6 | 20 | 2 | HP:0002700 | |
| HumanPheno | Aplasia/Hypoplasia of the thumb | 2.25e-04 | 150 | 20 | 5 | HP:0009601 | |
| HumanPheno | Thick eyebrow | 2.54e-04 | 154 | 20 | 5 | HP:0000574 | |
| HumanPheno | Abnormal cardiac atrium morphology | 2.58e-04 | 617 | 20 | 9 | HP:0005120 | |
| HumanPheno | Persistent left superior vena cava | 2.60e-04 | 83 | 20 | 4 | HP:0005301 | |
| HumanPheno | Syringomyelia | 2.62e-04 | 33 | 20 | 3 | HP:0003396 | |
| HumanPheno | Abnormal branching pattern of the aortic arch | 2.62e-04 | 33 | 20 | 3 | HP:0011587 | |
| HumanPheno | Delayed gross motor development | 2.70e-04 | 481 | 20 | 8 | HP:0002194 | |
| HumanPheno | Elbow dislocation | 2.73e-04 | 84 | 20 | 4 | HP:0003042 | |
| HumanPheno | Intestinal malrotation | 2.78e-04 | 157 | 20 | 5 | HP:0002566 | |
| HumanPheno | Abnormal superior vena cava morphology | 2.85e-04 | 85 | 20 | 4 | HP:0025575 | |
| HumanPheno | Aspiration | 2.87e-04 | 34 | 20 | 3 | HP:0002835 | |
| HumanPheno | Deviated nasal septum | 3.04e-04 | 7 | 20 | 2 | HP:0004411 | |
| HumanPheno | Generalized hypertrichosis | 3.04e-04 | 7 | 20 | 2 | HP:0004554 | |
| HumanPheno | Abnormal vena cava morphology | 3.26e-04 | 88 | 20 | 4 | HP:0030971 | |
| HumanPheno | Abnormality of the distal phalanx of the thumb | 3.40e-04 | 36 | 20 | 3 | HP:0009617 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the toes | 3.40e-04 | 36 | 20 | 3 | HP:0010173 | |
| HumanPheno | Abnormal vena cava morphology | 3.41e-04 | 89 | 20 | 4 | HP:0005345 | |
| HumanPheno | Broad thumb | 3.56e-04 | 90 | 20 | 4 | HP:0011304 | |
| HumanPheno | Prominent forehead | 3.60e-04 | 261 | 20 | 6 | HP:0011220 | |
| HumanPheno | Spina bifida | 4.14e-04 | 171 | 20 | 5 | HP:0002414 | |
| HumanPheno | Patent ductus arteriosus | 4.15e-04 | 382 | 20 | 7 | HP:0001643 | |
| HumanPheno | Abnormal distal phalanx morphology of finger | 4.48e-04 | 174 | 20 | 5 | HP:0009832 | |
| HumanPheno | Upper extremity joint dislocation | 4.55e-04 | 96 | 20 | 4 | HP:0030310 | |
| HumanPheno | Sandal gap | 4.55e-04 | 96 | 20 | 4 | HP:0001852 | |
| HumanPheno | Joint dislocation | 4.71e-04 | 390 | 20 | 7 | HP:0001373 | |
| HumanPheno | Cervical cord compression | 5.19e-04 | 9 | 20 | 2 | HP:0002341 | |
| HumanPheno | Deviation of finger | 5.77e-04 | 537 | 20 | 8 | HP:0004097 | |
| HumanPheno | Juvenile aseptic necrosis | 5.78e-04 | 43 | 20 | 3 | HP:0100323 | |
| HumanPheno | Abnormal facial expression | 5.95e-04 | 185 | 20 | 5 | HP:0005346 | |
| HumanPheno | Atrial septal defect | 6.07e-04 | 541 | 20 | 8 | HP:0001631 | |
| HumanPheno | Abnormality of the atrial septum | 6.07e-04 | 541 | 20 | 8 | HP:0001630 | |
| HumanPheno | Spinal dysraphism | 6.10e-04 | 186 | 20 | 5 | HP:0010301 | |
| HumanPheno | Meningioma | 6.19e-04 | 44 | 20 | 3 | HP:0002858 | |
| HumanPheno | Abnormal atrial septum morphology | 6.30e-04 | 544 | 20 | 8 | HP:0011994 | |
| HumanPheno | Frontal hirsutism | 6.47e-04 | 10 | 20 | 2 | HP:0011335 | |
| HumanPheno | Chiari malformation | 6.88e-04 | 107 | 20 | 4 | HP:0002308 | |
| HumanPheno | Spinal cord lesion | 7.06e-04 | 46 | 20 | 3 | HP:0100561 | |
| HumanPheno | Abnormal aortic arch morphology | 7.38e-04 | 109 | 20 | 4 | HP:0012303 | |
| HumanPheno | Clinodactyly of the 5th finger | 7.41e-04 | 420 | 20 | 7 | HP:0004209 | |
| HumanPheno | Clinodactyly of hands | 7.51e-04 | 421 | 20 | 7 | HP:0001157 | |
| HumanPheno | Deviation of the 5th finger | 7.51e-04 | 421 | 20 | 7 | HP:0009179 | |
| HumanPheno | Prominent nose | 7.64e-04 | 110 | 20 | 4 | HP:0000448 | |
| HumanPheno | Cochlear malformation | 7.89e-04 | 11 | 20 | 2 | HP:0008554 | |
| HumanPheno | Abnormal subclavian artery morphology | 7.89e-04 | 11 | 20 | 2 | HP:0031251 | |
| HumanPheno | Abnormality of mouth size | 7.95e-04 | 425 | 20 | 7 | HP:0011337 | |
| HumanPheno | Hypertrichosis | 7.95e-04 | 425 | 20 | 7 | HP:0000998 | |
| HumanPheno | Chiari type I malformation | 8.00e-04 | 48 | 20 | 3 | HP:0007099 | |
| HumanPheno | Deviation of the hand or of fingers of the hand | 8.05e-04 | 564 | 20 | 8 | HP:0009484 | |
| HumanPheno | Umbilical hernia | 8.45e-04 | 306 | 20 | 6 | HP:0001537 | |
| Domain | Nuc_rcpt_coact | 1.44e-09 | 6 | 60 | 4 | IPR009110 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.01e-05 | 2 | 60 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.01e-05 | 2 | 60 | 2 | PF08214 | |
| Domain | KIX | 1.01e-05 | 2 | 60 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 1.01e-05 | 2 | 60 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.01e-05 | 2 | 60 | 2 | IPR031162 | |
| Domain | DUF902 | 1.01e-05 | 2 | 60 | 2 | PF06001 | |
| Domain | - | 1.01e-05 | 2 | 60 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.01e-05 | 2 | 60 | 2 | IPR010303 | |
| Domain | - | 1.01e-05 | 2 | 60 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.01e-05 | 2 | 60 | 2 | PF09030 | |
| Domain | - | 1.01e-05 | 2 | 60 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.01e-05 | 2 | 60 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.01e-05 | 2 | 60 | 2 | PS50134 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.01e-05 | 2 | 60 | 2 | IPR013178 | |
| Domain | KAT11 | 1.01e-05 | 2 | 60 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.01e-05 | 2 | 60 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.01e-05 | 2 | 60 | 2 | IPR003101 | |
| Domain | KIX | 1.01e-05 | 2 | 60 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 1.01e-05 | 2 | 60 | 2 | PS51727 | |
| Domain | DUF1518 | 3.04e-05 | 3 | 60 | 2 | PF07469 | |
| Domain | DUF1518 | 3.04e-05 | 3 | 60 | 2 | IPR010011 | |
| Domain | Nuc_rcpt_coact_Ncoa-typ | 3.04e-05 | 3 | 60 | 2 | IPR014920 | |
| Domain | SRC-1 | 3.04e-05 | 3 | 60 | 2 | IPR014935 | |
| Domain | Src1_rcpt_coact | 3.04e-05 | 3 | 60 | 2 | IPR008955 | |
| Domain | Nuclear_rcpt_coactivator | 3.04e-05 | 3 | 60 | 2 | IPR017426 | |
| Domain | DUF1518 | 3.04e-05 | 3 | 60 | 2 | SM01151 | |
| Domain | SRC-1 | 3.04e-05 | 3 | 60 | 2 | PF08832 | |
| Domain | - | 3.04e-05 | 3 | 60 | 2 | 4.10.630.10 | |
| Domain | Nuc_rec_co-act | 3.04e-05 | 3 | 60 | 2 | PF08815 | |
| Domain | PAS | 6.89e-05 | 25 | 60 | 3 | PF00989 | |
| Domain | PAS_fold | 6.89e-05 | 25 | 60 | 3 | IPR013767 | |
| Domain | PAS | 1.46e-04 | 32 | 60 | 3 | SM00091 | |
| Domain | PAS | 1.76e-04 | 34 | 60 | 3 | IPR000014 | |
| Domain | PAS | 1.76e-04 | 34 | 60 | 3 | PS50112 | |
| Domain | Kelch-typ_b-propeller | 7.34e-04 | 55 | 60 | 3 | IPR015915 | |
| Domain | Gal_Oxase/kelch_b-propeller | 9.02e-04 | 59 | 60 | 3 | IPR011043 | |
| Domain | Kelch_1 | 1.48e-03 | 70 | 60 | 3 | PF01344 | |
| Domain | Kelch_1 | 1.48e-03 | 70 | 60 | 3 | IPR006652 | |
| Domain | ZZ | 1.50e-03 | 18 | 60 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 1.50e-03 | 18 | 60 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.50e-03 | 18 | 60 | 2 | PS01357 | |
| Domain | Znf_ZZ | 1.68e-03 | 19 | 60 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 1.68e-03 | 19 | 60 | 2 | SM00291 | |
| Domain | PAC | 3.14e-03 | 26 | 60 | 2 | IPR001610 | |
| Domain | Bromodomain_CS | 3.14e-03 | 26 | 60 | 2 | IPR018359 | |
| Domain | PAC | 3.14e-03 | 26 | 60 | 2 | SM00086 | |
| Domain | S_TKc | 5.87e-03 | 359 | 60 | 5 | SM00220 | |
| Domain | HLH | 6.18e-03 | 116 | 60 | 3 | SM00353 | |
| Domain | BROMODOMAIN_1 | 6.29e-03 | 37 | 60 | 2 | PS00633 | |
| Domain | Bromodomain | 6.62e-03 | 38 | 60 | 2 | PF00439 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 3.80e-07 | 18 | 49 | 4 | M26942 | |
| Pathway | PID_HES_HEY_PATHWAY | 6.30e-07 | 48 | 49 | 5 | M288 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 6.85e-07 | 91 | 49 | 6 | M39700 | |
| Pathway | REACTOME_HEME_SIGNALING | 6.99e-07 | 49 | 49 | 5 | M41832 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.30e-06 | 24 | 49 | 4 | M13404 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.18e-06 | 8 | 49 | 3 | M22058 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 2.49e-06 | 63 | 49 | 5 | MM15613 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 2.91e-06 | 65 | 49 | 5 | M39682 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 3.30e-06 | 30 | 49 | 4 | M207 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.94e-06 | 272 | 49 | 8 | M29619 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 4.20e-06 | 70 | 49 | 5 | M938 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 7.82e-06 | 37 | 49 | 4 | M29790 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 9.18e-06 | 82 | 49 | 5 | M2 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.03e-05 | 84 | 49 | 5 | M1008 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 1.21e-05 | 149 | 49 | 6 | M27888 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.40e-05 | 14 | 49 | 3 | M27808 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.58e-05 | 44 | 49 | 4 | M27295 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 2.06e-05 | 47 | 49 | 4 | M29777 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 2.14e-05 | 16 | 49 | 3 | M27121 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.24e-05 | 48 | 49 | 4 | M611 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 2.59e-05 | 17 | 49 | 3 | M48025 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 3.08e-05 | 52 | 49 | 4 | M2404 | |
| Pathway | PID_AR_TF_PATHWAY | 3.33e-05 | 53 | 49 | 4 | M151 | |
| Pathway | REACTOME_ADIPOGENESIS | 3.83e-05 | 110 | 49 | 5 | M48259 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 3.86e-05 | 55 | 49 | 4 | M27145 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 3.86e-05 | 55 | 49 | 4 | M27001 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.32e-05 | 20 | 49 | 3 | M27881 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 4.76e-05 | 58 | 49 | 4 | M29616 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 5.36e-05 | 118 | 49 | 5 | M27316 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 5.44e-05 | 60 | 49 | 4 | M41830 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 5.80e-05 | 22 | 49 | 3 | MM1370 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 6.76e-05 | 296 | 49 | 7 | M27869 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 7.02e-05 | 64 | 49 | 4 | M200 | |
| Pathway | PID_HIF1_TFPATHWAY | 7.92e-05 | 66 | 49 | 4 | M255 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS | 8.34e-05 | 210 | 49 | 6 | M41836 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 8.60e-05 | 25 | 49 | 3 | M27880 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 9.47e-05 | 133 | 49 | 5 | MM15529 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 1.08e-04 | 220 | 49 | 6 | M27794 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 1.09e-04 | 27 | 49 | 3 | M26943 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.18e-04 | 5 | 49 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.18e-04 | 5 | 49 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.18e-04 | 5 | 49 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.18e-04 | 5 | 49 | 2 | M48023 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.22e-04 | 28 | 49 | 3 | M6177 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.24e-04 | 74 | 49 | 4 | M616 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.76e-04 | 6 | 49 | 2 | M22062 | |
| Pathway | PID_REG_GR_PATHWAY | 1.85e-04 | 82 | 49 | 4 | M115 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | NCOA2 NCOR1 PIK3C2B SEC24A NCOA1 PLA2G4D CREBBP EP300 PLIN3 MTMR9 | 2.29e-04 | 757 | 49 | 10 | M27451 |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.46e-04 | 7 | 49 | 2 | MM1573 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 3.27e-04 | 8 | 49 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 3.27e-04 | 8 | 49 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 3.27e-04 | 8 | 49 | 2 | M46443 | |
| Pathway | REACTOME_MITOCHONDRIAL_BIOGENESIS | 3.38e-04 | 96 | 49 | 4 | M26973 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 4.12e-04 | 42 | 49 | 3 | M17541 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 4.12e-04 | 42 | 49 | 3 | M27172 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 4.20e-04 | 9 | 49 | 2 | M29809 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M47451 | |
| Pathway | PID_HNF3A_PATHWAY | 4.73e-04 | 44 | 49 | 3 | M285 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 5.09e-04 | 191 | 49 | 5 | MM15586 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 5.23e-04 | 10 | 49 | 2 | MM1401 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 5.23e-04 | 10 | 49 | 2 | M477 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 5.23e-04 | 10 | 49 | 2 | MM15535 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 5.23e-04 | 10 | 49 | 2 | M27945 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 5.75e-04 | 47 | 49 | 3 | M7946 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 6.38e-04 | 11 | 49 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 6.38e-04 | 11 | 49 | 2 | M48021 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 6.38e-04 | 11 | 49 | 2 | M47503 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 6.38e-04 | 11 | 49 | 2 | M26924 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 6.50e-04 | 49 | 49 | 3 | M618 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 7.64e-04 | 12 | 49 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 7.64e-04 | 12 | 49 | 2 | M27765 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 7.64e-04 | 12 | 49 | 2 | M27159 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 9.01e-04 | 13 | 49 | 2 | MM15622 | |
| Pathway | REACTOME_GASTRULATION | 1.03e-03 | 129 | 49 | 4 | M46433 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.05e-03 | 14 | 49 | 2 | M27074 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.05e-03 | 14 | 49 | 2 | MM14748 | |
| Pathway | PID_NOTCH_PATHWAY | 1.12e-03 | 59 | 49 | 3 | M17 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.21e-03 | 15 | 49 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.21e-03 | 15 | 49 | 2 | MM1439 | |
| Pathway | PID_ERB_GENOMIC_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M119 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 1.21e-03 | 15 | 49 | 2 | M953 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.23e-03 | 61 | 49 | 3 | M39540 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.38e-03 | 16 | 49 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.38e-03 | 16 | 49 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.38e-03 | 16 | 49 | 2 | M8516 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.38e-03 | 16 | 49 | 2 | M27940 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 1.47e-03 | 142 | 49 | 4 | M27233 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 1.55e-03 | 66 | 49 | 3 | M101 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.56e-03 | 17 | 49 | 2 | MM1509 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 1.75e-03 | 18 | 49 | 2 | M4862 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.75e-03 | 18 | 49 | 2 | MM15034 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.75e-03 | 18 | 49 | 2 | MM14775 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 1.76e-03 | 69 | 49 | 3 | M46439 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.95e-03 | 19 | 49 | 2 | M18933 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 1.95e-03 | 19 | 49 | 2 | MM14612 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 1.95e-03 | 19 | 49 | 2 | M46442 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 1.98e-03 | 154 | 49 | 4 | M27832 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS | 2.38e-03 | 162 | 49 | 4 | MM15688 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 2.38e-03 | 21 | 49 | 2 | M39593 | |
| Pubmed | SCYL2 NCOA2 GPHN NCOR1 ARID1B ZNF148 ERC1 CSTF2 KEAP1 SRCAP RFX1 CREBBP EP300 PLIN3 KDM1A | 2.82e-14 | 549 | 61 | 15 | 38280479 | |
| Pubmed | 2.76e-13 | 17 | 61 | 6 | 19183483 | ||
| Pubmed | 2.13e-10 | 20 | 61 | 5 | 11877444 | ||
| Pubmed | 2.80e-10 | 21 | 61 | 5 | 19596656 | ||
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 2.98e-10 | 7 | 61 | 4 | 9590696 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | CPEB2 NCOA2 BCL9L NCOR1 ARID1B SEC24A AGFG2 PUM2 CREBBP MAML3 EP300 | 4.14e-10 | 457 | 61 | 11 | 32344865 |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA2 BCL9L NCOR1 ARID1B ZNF148 ZSCAN4 NCOA1 CREBBP EP300 KDM1A | 5.51e-10 | 351 | 61 | 10 | 38297188 |
| Pubmed | 1.02e-09 | 268 | 61 | 9 | 33640491 | ||
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 1.78e-09 | 10 | 61 | 4 | 30595551 | |
| Pubmed | NCOA2 BCL9L NCOR1 ARID1B ZNF148 SEC24A CSTF2 NCOA1 PUM2 SRCAP FOXA1 RFX1 CREBBP TRIB1 EP300 KDM1A | 2.14e-09 | 1429 | 61 | 16 | 35140242 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NCOA2 GPHN NCOR1 ZNF148 EBF3 FBXO42 ISL1 FOXA1 RFX1 CREBBP TRIB1 EP300 KDM1A | 2.49e-09 | 857 | 61 | 13 | 25609649 |
| Pubmed | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. | 2.80e-09 | 11 | 61 | 4 | 15681609 | |
| Pubmed | Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors. | 5.13e-09 | 3 | 61 | 3 | 24550004 | |
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 10347196 | ||
| Pubmed | 7.68e-09 | 83 | 61 | 6 | 28794006 | ||
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 8.81e-09 | 40 | 61 | 5 | 34585037 | |
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 11581372 | ||
| Pubmed | Direct association between the CREB-binding protein (CBP) and nuclear receptor corepressor (N-CoR). | 2.05e-08 | 4 | 61 | 3 | 17073437 | |
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 12208951 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 11463834 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 11113179 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 10899165 | ||
| Pubmed | A simple method to screen ligands of peroxisome proliferator-activated receptor delta. | 2.05e-08 | 4 | 61 | 3 | 16930961 | |
| Pubmed | A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. | 2.05e-08 | 4 | 61 | 3 | 10339548 | |
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 12714702 | ||
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 14722092 | ||
| Pubmed | SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. | 5.12e-08 | 5 | 61 | 3 | 9812974 | |
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 10803578 | ||
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 14985122 | ||
| Pubmed | 5.48e-08 | 57 | 61 | 5 | 18022353 | ||
| Pubmed | 7.39e-08 | 23 | 61 | 4 | 19737349 | ||
| Pubmed | 1.02e-07 | 6 | 61 | 3 | 17468099 | ||
| Pubmed | Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. | 1.02e-07 | 6 | 61 | 3 | 11076796 | |
| Pubmed | 1.02e-07 | 6 | 61 | 3 | 16373399 | ||
| Pubmed | Role of CBP in regulating HIF-1-mediated activation of transcription. | 1.02e-07 | 6 | 61 | 3 | 15615775 | |
| Pubmed | 1.02e-07 | 6 | 61 | 3 | 10973497 | ||
| Pubmed | 1.02e-07 | 6 | 61 | 3 | 16923966 | ||
| Pubmed | 1.02e-07 | 6 | 61 | 3 | 10497212 | ||
| Pubmed | 1.02e-07 | 6 | 61 | 3 | 15731352 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.20e-07 | 220 | 61 | 7 | 35785414 | |
| Pubmed | 1.70e-07 | 28 | 61 | 4 | 24880616 | ||
| Pubmed | BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells. | 1.79e-07 | 7 | 61 | 3 | 16860316 | |
| Pubmed | The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. | 1.79e-07 | 7 | 61 | 3 | 9192892 | |
| Pubmed | 1.79e-07 | 7 | 61 | 3 | 12709428 | ||
| Pubmed | 2.69e-07 | 78 | 61 | 5 | 28611094 | ||
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 12082103 | ||
| Pubmed | Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase. | 2.86e-07 | 8 | 61 | 3 | 11971985 | |
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 20935208 | ||
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 17475621 | ||
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 10490106 | ||
| Pubmed | 3.82e-07 | 34 | 61 | 4 | 30894540 | ||
| Pubmed | NCOA2 NCOR1 ARID1B UBQLN1 ZNF148 EBF3 NCOA1 RFX1 CREBBP EP300 PLIN3 KDM1A | 4.05e-07 | 1103 | 61 | 12 | 34189442 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 4.76e-07 | 398 | 61 | 8 | 35016035 | |
| Pubmed | ARID1B RPS6KA4 KCNH1 GGTLC1 KEAP1 SIK3 CREBBP EP300 KDM1A MTMR9 | 5.36e-07 | 730 | 61 | 10 | 34857952 | |
| Pubmed | 6.11e-07 | 10 | 61 | 3 | 25223786 | ||
| Pubmed | 6.11e-07 | 10 | 61 | 3 | 12738788 | ||
| Pubmed | 6.11e-07 | 10 | 61 | 3 | 15001550 | ||
| Pubmed | 8.39e-07 | 11 | 61 | 3 | 10454579 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 8.42e-07 | 588 | 61 | 9 | 38580884 | |
| Pubmed | 8.54e-07 | 183 | 61 | 6 | 36129980 | ||
| Pubmed | 8.79e-07 | 591 | 61 | 9 | 15231748 | ||
| Pubmed | 1.12e-06 | 12 | 61 | 3 | 12189208 | ||
| Pubmed | 1.45e-06 | 13 | 61 | 3 | 19524524 | ||
| Pubmed | 1.45e-06 | 13 | 61 | 3 | 11266503 | ||
| Pubmed | 1.65e-06 | 638 | 61 | 9 | 31182584 | ||
| Pubmed | MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. | 1.84e-06 | 14 | 61 | 3 | 17641689 | |
| Pubmed | 1.84e-06 | 14 | 61 | 3 | 12482968 | ||
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 1.84e-06 | 14 | 61 | 3 | 11500849 | |
| Pubmed | E protein silencing by the leukemogenic AML1-ETO fusion protein. | 1.84e-06 | 14 | 61 | 3 | 15333839 | |
| Pubmed | 2.30e-06 | 15 | 61 | 3 | 15674325 | ||
| Pubmed | Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules. | 2.83e-06 | 16 | 61 | 3 | 22780989 | |
| Pubmed | Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior. | 2.94e-06 | 56 | 61 | 4 | 29184203 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 3.03e-06 | 2 | 61 | 2 | 34845315 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 19729597 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 15860545 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 3.03e-06 | 2 | 61 | 2 | 24551300 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 33911074 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 9018065 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 24648406 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 30135524 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 39287984 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 3.03e-06 | 2 | 61 | 2 | 16596650 | |
| Pubmed | SRC-1 and TIF2 control energy balance between white and brown adipose tissues. | 3.03e-06 | 2 | 61 | 2 | 12507421 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 3.03e-06 | 2 | 61 | 2 | 29217654 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 20717166 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 10049825 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 3.03e-06 | 2 | 61 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 3.03e-06 | 2 | 61 | 2 | 29170789 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 25893291 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 11559821 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 3.03e-06 | 2 | 61 | 2 | 12646247 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 32576962 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 19822209 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 24522976 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 3.03e-06 | 2 | 61 | 2 | 21847097 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 3.03e-06 | 2 | 61 | 2 | 11963968 | |
| Interaction | TLE3 interactions | NCOA2 BCL9L NCOR1 ARID1B EBF3 SEC24A AGFG2 CSTF2 NCOA1 FOXA1 CREBBP EP300 KDM1A | 6.32e-11 | 376 | 60 | 13 | int:TLE3 |
| Interaction | WWTR1 interactions | SCYL2 NCOA2 GPHN NCOR1 ARID1B ERC1 CSTF2 KEAP1 SRCAP CREBBP EP300 PLIN3 | 3.43e-09 | 422 | 60 | 12 | int:WWTR1 |
| Interaction | HNF4A interactions | NCOA2 NCOR1 ARID1B ZNF148 NCOA1 ISL1 SRCAP CREBBP EP300 KDM1A | 7.86e-09 | 275 | 60 | 10 | int:HNF4A |
| Interaction | NCOA3 interactions | 1.99e-08 | 224 | 60 | 9 | int:NCOA3 | |
| Interaction | SP7 interactions | NCOA2 BCL9L NCOR1 ARID1B ZNF148 NCOA1 RFX1 CREBBP EP300 KDM1A | 2.04e-08 | 304 | 60 | 10 | int:SP7 |
| Interaction | EGR2 interactions | 4.01e-08 | 171 | 60 | 8 | int:EGR2 | |
| Interaction | NUP35 interactions | CPEB2 NCOA2 BCL9L NCOR1 ARID1B SEC24A AGFG2 PUM2 CREBBP MAML3 EP300 | 4.26e-08 | 424 | 60 | 11 | int:NUP35 |
| Interaction | TBXT interactions | 5.23e-08 | 116 | 60 | 7 | int:TBXT | |
| Interaction | ETS1 interactions | 7.01e-08 | 121 | 60 | 7 | int:ETS1 | |
| Interaction | SOX7 interactions | 1.58e-07 | 82 | 60 | 6 | int:SOX7 | |
| Interaction | STAT6 interactions | 2.26e-07 | 87 | 60 | 6 | int:STAT6 | |
| Interaction | TPRX2 interactions | 6.71e-07 | 56 | 60 | 5 | int:TPRX2 | |
| Interaction | NR6A1 interactions | 7.21e-07 | 24 | 60 | 4 | int:NR6A1 | |
| Interaction | NR1H3 interactions | 8.01e-07 | 58 | 60 | 5 | int:NR1H3 | |
| Interaction | NFIA interactions | 1.40e-06 | 188 | 60 | 7 | int:NFIA | |
| Interaction | MYOD1 interactions | 1.72e-06 | 194 | 60 | 7 | int:MYOD1 | |
| Interaction | FEV interactions | 2.33e-06 | 203 | 60 | 7 | int:FEV | |
| Interaction | TRERF1 interactions | 2.72e-06 | 33 | 60 | 4 | int:TRERF1 | |
| Interaction | NFIC interactions | 2.92e-06 | 210 | 60 | 7 | int:NFIC | |
| Interaction | YAP1 interactions | GPHN BCL9L NCOR1 ARID1B UBQLN1 ZNF148 ERC1 SRCAP FOXA1 RFX1 CREBBP EP300 PLIN3 KDM1A | 2.98e-06 | 1095 | 60 | 14 | int:YAP1 |
| Interaction | FOS interactions | 3.84e-06 | 312 | 60 | 8 | int:FOS | |
| Interaction | HOXB2 interactions | 3.89e-06 | 36 | 60 | 4 | int:HOXB2 | |
| Interaction | NFIB interactions | 4.03e-06 | 142 | 60 | 6 | int:NFIB | |
| Interaction | RORA interactions | 5.40e-06 | 39 | 60 | 4 | int:RORA | |
| Interaction | TFF1 interactions | 6.62e-06 | 41 | 60 | 4 | int:TFF1 | |
| Interaction | RASSF8 interactions | 7.54e-06 | 91 | 60 | 5 | int:RASSF8 | |
| Interaction | EYA4 interactions | 7.62e-06 | 243 | 60 | 7 | int:EYA4 | |
| Interaction | LHX4 interactions | 9.89e-06 | 166 | 60 | 6 | int:LHX4 | |
| Interaction | CRX interactions | 1.02e-05 | 254 | 60 | 7 | int:CRX | |
| Interaction | SS18L1 interactions | 1.08e-05 | 98 | 60 | 5 | int:SS18L1 | |
| Interaction | NR1I2 interactions | 1.25e-05 | 48 | 60 | 4 | int:NR1I2 | |
| Interaction | TEAD1 interactions | 1.38e-05 | 176 | 60 | 6 | int:TEAD1 | |
| Interaction | YWHAH interactions | NCOA2 RPS6KA4 SH3RF1 LMBR1L PIK3C2B ERC1 SEC24A NCOA1 TAOK1 SIK3 CREBBP TMCC1 KIF1C | 1.70e-05 | 1102 | 60 | 13 | int:YWHAH |
| Interaction | GATA3 interactions | 1.95e-05 | 187 | 60 | 6 | int:GATA3 | |
| Interaction | PAX8 interactions | 1.99e-05 | 111 | 60 | 5 | int:PAX8 | |
| Interaction | THRA interactions | 1.99e-05 | 111 | 60 | 5 | int:THRA | |
| Interaction | TBR1 interactions | 2.17e-05 | 113 | 60 | 5 | int:TBR1 | |
| Interaction | BCL3 interactions | 2.32e-05 | 56 | 60 | 4 | int:BCL3 | |
| Interaction | LDB2 interactions | 2.32e-05 | 56 | 60 | 4 | int:LDB2 | |
| Interaction | KLF5 interactions | 2.46e-05 | 195 | 60 | 6 | int:KLF5 | |
| Interaction | PPARD interactions | 2.56e-05 | 117 | 60 | 5 | int:PPARD | |
| Interaction | NR2F1 interactions | 2.67e-05 | 58 | 60 | 4 | int:NR2F1 | |
| Interaction | AR interactions | NCOA2 BCL9L NCOR1 ARID1B ZNF148 NCOA1 SRCAP FOXA1 APOL2 CREBBP EP300 KDM1A | 2.97e-05 | 992 | 60 | 12 | int:AR |
| Interaction | ETS2 interactions | 3.26e-05 | 61 | 60 | 4 | int:ETS2 | |
| Interaction | USP9X interactions | 3.41e-05 | 422 | 60 | 8 | int:USP9X | |
| Interaction | CEBPD interactions | 3.48e-05 | 62 | 60 | 4 | int:CEBPD | |
| Interaction | VDR interactions | 3.80e-05 | 127 | 60 | 5 | int:VDR | |
| Interaction | SRCAP interactions | 3.80e-05 | 127 | 60 | 5 | int:SRCAP | |
| Interaction | PAX9 interactions | 4.25e-05 | 130 | 60 | 5 | int:PAX9 | |
| Interaction | SMG7 interactions | 4.39e-05 | 319 | 60 | 7 | int:SMG7 | |
| Interaction | CARM1 interactions | 4.93e-05 | 325 | 60 | 7 | int:CARM1 | |
| Interaction | GCM1 interactions | 5.01e-05 | 68 | 60 | 4 | int:GCM1 | |
| Interaction | NR1H2 interactions | 5.01e-05 | 68 | 60 | 4 | int:NR1H2 | |
| Interaction | RARA interactions | 5.22e-05 | 223 | 60 | 6 | int:RARA | |
| Interaction | ERG interactions | 5.22e-05 | 223 | 60 | 6 | int:ERG | |
| Interaction | ETV4 interactions | 5.31e-05 | 69 | 60 | 4 | int:ETV4 | |
| Interaction | NFIX interactions | 5.76e-05 | 227 | 60 | 6 | int:NFIX | |
| Interaction | CEBPA interactions | NCOA2 NCOR1 ARID1B UBQLN1 ZNF148 EBF3 NCOA1 RFX1 CREBBP TRIB1 EP300 PLIN3 KDM1A | 6.07e-05 | 1245 | 60 | 13 | int:CEBPA |
| Interaction | NCOA2 interactions | 6.26e-05 | 141 | 60 | 5 | int:NCOA2 | |
| Interaction | SMARCA4 interactions | 6.46e-05 | 462 | 60 | 8 | int:SMARCA4 | |
| Interaction | NCOA6 interactions | 7.15e-05 | 145 | 60 | 5 | int:NCOA6 | |
| Interaction | NCOA1 interactions | 7.38e-05 | 146 | 60 | 5 | int:NCOA1 | |
| Interaction | TP53BP2 interactions | 8.02e-05 | 241 | 60 | 6 | int:TP53BP2 | |
| Interaction | TACC2 interactions | 8.17e-05 | 77 | 60 | 4 | int:TACC2 | |
| Interaction | SMARCC2 interactions | 8.29e-05 | 353 | 60 | 7 | int:SMARCC2 | |
| Interaction | CBFA2T3 interactions | 8.59e-05 | 78 | 60 | 4 | int:CBFA2T3 | |
| Interaction | SEC14L5 interactions | 8.67e-05 | 5 | 60 | 2 | int:SEC14L5 | |
| Interaction | SMAD9 interactions | 9.22e-05 | 153 | 60 | 5 | int:SMAD9 | |
| Interaction | PAX6 interactions | 1.04e-04 | 366 | 60 | 7 | int:PAX6 | |
| Interaction | SPATA1 interactions | 1.06e-04 | 31 | 60 | 3 | int:SPATA1 | |
| Interaction | CRTC1 interactions | 1.06e-04 | 31 | 60 | 3 | int:CRTC1 | |
| Interaction | CREB1 interactions | 1.07e-04 | 254 | 60 | 6 | int:CREB1 | |
| Interaction | DNMT1 interactions | 1.07e-04 | 254 | 60 | 6 | int:DNMT1 | |
| Interaction | RBPJ interactions | 1.07e-04 | 254 | 60 | 6 | int:RBPJ | |
| Interaction | CPSF1 interactions | 1.09e-04 | 255 | 60 | 6 | int:CPSF1 | |
| Interaction | IRF1 interactions | 1.09e-04 | 83 | 60 | 4 | int:IRF1 | |
| Interaction | NFE2L2 interactions | 1.10e-04 | 159 | 60 | 5 | int:NFE2L2 | |
| Interaction | UBQLN2 interactions | SCYL2 UBQLN1 SH3RF1 FAM168A LMBR1L SEC24A AGFG2 CSTF2 APOL2 PLIN3 | 1.11e-04 | 797 | 60 | 10 | int:UBQLN2 |
| Interaction | CTBP2 interactions | 1.11e-04 | 370 | 60 | 7 | int:CTBP2 | |
| Interaction | PGR interactions | 1.15e-04 | 84 | 60 | 4 | int:PGR | |
| Interaction | NR1H4 interactions | 1.17e-04 | 32 | 60 | 3 | int:NR1H4 | |
| Interaction | NR3C1 interactions | NCOA2 NCOR1 ARID1B FBXO42 NCOA1 SIK3 RFX1 CREBBP MAML3 EP300 KDM1A | 1.23e-04 | 974 | 60 | 11 | int:NR3C1 |
| Interaction | GSC interactions | 1.31e-04 | 87 | 60 | 4 | int:GSC | |
| Interaction | SMARCC1 interactions | 1.40e-04 | 384 | 60 | 7 | int:SMARCC1 | |
| Interaction | TFAP2D interactions | 1.43e-04 | 89 | 60 | 4 | int:TFAP2D | |
| Interaction | RXRA interactions | 1.47e-04 | 169 | 60 | 5 | int:RXRA | |
| Interaction | NRIP1 interactions | 1.51e-04 | 170 | 60 | 5 | int:NRIP1 | |
| Interaction | PPARA interactions | 1.63e-04 | 92 | 60 | 4 | int:PPARA | |
| Interaction | SOX10 interactions | 1.63e-04 | 92 | 60 | 4 | int:SOX10 | |
| Interaction | SMAD4 interactions | 1.67e-04 | 530 | 60 | 8 | int:SMAD4 | |
| Interaction | E2F5 interactions | 1.67e-04 | 36 | 60 | 3 | int:E2F5 | |
| Interaction | ARID1A interactions | 1.68e-04 | 276 | 60 | 6 | int:ARID1A | |
| Interaction | TLX1 interactions | 1.73e-04 | 175 | 60 | 5 | int:TLX1 | |
| Interaction | PIAS3 interactions | 1.85e-04 | 95 | 60 | 4 | int:PIAS3 | |
| Interaction | NKX2-1 interactions | 1.97e-04 | 180 | 60 | 5 | int:NKX2-1 | |
| Interaction | EP300 interactions | NCOA2 GPHN NCOR1 MEX3A UBQLN1 ZNF148 SEC24A NCOA1 KEAP1 SRCAP CREBBP EP300 KDM1A | 1.99e-04 | 1401 | 60 | 13 | int:EP300 |
| Interaction | SOX9 interactions | 2.00e-04 | 97 | 60 | 4 | int:SOX9 | |
| Interaction | UNK interactions | 2.03e-04 | 408 | 60 | 7 | int:UNK | |
| Interaction | ALG13 interactions | 2.13e-04 | 183 | 60 | 5 | int:ALG13 | |
| Interaction | KLF15 interactions | 2.20e-04 | 290 | 60 | 6 | int:KLF15 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 8.52e-08 | 17 | 46 | 4 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 9.44e-04 | 18 | 46 | 2 | 91 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA2 ZNF148 FAM168A ERC1 SEC24A MKLN1 NCOA1 PUM2 SIK3 CREBBP TMCC1 | 3.36e-06 | 856 | 60 | 11 | M4500 |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 6.32e-06 | 199 | 60 | 6 | M9443 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 6.32e-06 | 199 | 60 | 6 | M7254 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 9.07e-06 | 212 | 60 | 6 | M39221 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | LMBR1L SEC24A MKLN1 ADNP2 NCOA1 SIK3 CREBBP TRIB1 TMCC1 EP300 | 1.59e-05 | 822 | 60 | 10 | M6782 |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 1.81e-05 | 141 | 60 | 5 | M39235 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 5.81e-05 | 180 | 60 | 5 | M8239 | |
| Coexpression | GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP | 8.08e-05 | 193 | 60 | 5 | M3484 | |
| Coexpression | GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP | 8.69e-05 | 196 | 60 | 5 | M5569 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP | 9.34e-05 | 199 | 60 | 5 | M3478 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_2H_BMDC_UP | 9.34e-05 | 199 | 60 | 5 | M3711 | |
| Coexpression | GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN | 9.34e-05 | 199 | 60 | 5 | M7374 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP | 9.56e-05 | 200 | 60 | 5 | M7256 | |
| Coexpression | GSE40273_EOS_KO_VS_WT_TREG_DN | 9.56e-05 | 200 | 60 | 5 | M9130 | |
| Coexpression | GSE557_WT_VS_CIITA_KO_DC_DN | 9.56e-05 | 200 | 60 | 5 | M6008 | |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | 1.22e-04 | 845 | 60 | 9 | M18090 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 2.24e-04 | 240 | 60 | 5 | M39236 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SCYL2 UBQLN1 FAM168A FBXO42 PUM2 KEAP1 GFUS CREBBP KDM1A BORCS7 | 2.24e-04 | 1129 | 60 | 10 | M42508 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SCYL2 UBQLN1 FAM168A FBXO42 PUM2 KEAP1 GFUS CREBBP KDM1A BORCS7 | 2.74e-04 | 1158 | 60 | 10 | MM1338 |
| Coexpression | ZHOU_PANCREATIC_BETA_CELL | 2.80e-04 | 11 | 60 | 2 | MM1247 | |
| Coexpression | ZHOU_PANCREATIC_BETA_CELL | 2.80e-04 | 11 | 60 | 2 | M1863 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.28e-12 | 198 | 60 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-10 | 196 | 60 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.67e-10 | 199 | 60 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.64e-09 | 193 | 60 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-07 | 189 | 60 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-06 | 192 | 60 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| Drug | AC1L9M2J | 1.72e-06 | 76 | 60 | 5 | CID000448538 | |
| Drug | Cyproterone Acetate | 2.15e-06 | 35 | 60 | 4 | ctd:D017373 | |
| Drug | Androstenols | 3.76e-06 | 12 | 60 | 3 | ctd:D000737 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 6.50e-06 | 174 | 60 | 6 | 1659_DN | |
| Drug | dexamethasone 21-mesylate | 9.51e-06 | 16 | 60 | 3 | CID000063041 | |
| Drug | androst-2-en-3-ol | 1.38e-05 | 18 | 60 | 3 | CID000166036 | |
| Drug | AC1L2E0P | 1.59e-05 | 307 | 60 | 7 | CID000019390 | |
| Drug | iclaprim | 2.17e-05 | 62 | 60 | 4 | CID000213043 | |
| Drug | afimoxifene | 3.55e-05 | 479 | 60 | 8 | ctd:C016601 | |
| Drug | halofenate | 4.08e-05 | 4 | 60 | 2 | CID000033584 | |
| Drug | lithocholic acid acetate | 4.33e-05 | 26 | 60 | 3 | ctd:C502354 | |
| Drug | androstenol | 4.86e-05 | 27 | 60 | 3 | CID000101989 | |
| Drug | tetrac | 6.05e-05 | 29 | 60 | 3 | CID000065552 | |
| Drug | MF101 extract | 6.79e-05 | 5 | 60 | 2 | ctd:C517398 | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 6.79e-05 | 5 | 60 | 2 | ctd:C575894 | |
| Drug | AC1ND2OB | 6.95e-05 | 265 | 60 | 6 | CID004568637 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 9.06e-05 | 172 | 60 | 5 | 1072_DN | |
| Drug | Sp 1 (pharmaceutical) | 9.11e-05 | 548 | 60 | 8 | CID000099040 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 9.83e-05 | 175 | 60 | 5 | 1014_DN | |
| Drug | butamben | 1.02e-04 | 6 | 60 | 2 | ctd:C004605 | |
| Drug | 2',3',4',5'-tetrachloro-4-biphenylol | 1.02e-04 | 6 | 60 | 2 | ctd:C104006 | |
| Drug | L-165041 | 1.17e-04 | 36 | 60 | 3 | CID006603901 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.18e-04 | 182 | 60 | 5 | 3887_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.21e-04 | 183 | 60 | 5 | 4770_DN | |
| Drug | monastrol; Down 200; 100uM; MCF7; HG-U133A | 1.67e-04 | 196 | 60 | 5 | 627_DN | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; HL60; HT_HG-U133A | 1.67e-04 | 196 | 60 | 5 | 1326_UP | |
| Drug | Hexestrol [84-16-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.71e-04 | 197 | 60 | 5 | 6077_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 1.71e-04 | 197 | 60 | 5 | 7011_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | 1.71e-04 | 197 | 60 | 5 | 1640_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.75e-04 | 198 | 60 | 5 | 5871_DN | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.38e-06 | 41 | 59 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.38e-06 | 41 | 59 | 4 | C0858252 | |
| Disease | Menke-Hennekam syndrome | 3.93e-06 | 2 | 59 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 3.93e-06 | 2 | 59 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 3.93e-06 | 2 | 59 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 3.93e-06 | 2 | 59 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 3.93e-06 | 2 | 59 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 3.93e-06 | 2 | 59 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 3.93e-06 | 2 | 59 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 3.93e-06 | 2 | 59 | 2 | C0035934 | |
| Disease | Adenoid Cystic Carcinoma | 4.90e-05 | 100 | 59 | 4 | C0010606 | |
| Disease | polycystic ovary syndrome (implicated_via_orthology) | 5.87e-05 | 6 | 59 | 2 | DOID:11612 (implicated_via_orthology) | |
| Disease | Carcinoma, Transitional Cell | 7.67e-05 | 41 | 59 | 3 | C0007138 | |
| Disease | Breast Carcinoma | 9.68e-05 | 538 | 59 | 7 | C0678222 | |
| Disease | Bladder Neoplasm | 1.80e-04 | 140 | 59 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.85e-04 | 141 | 59 | 4 | C0005684 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.47e-04 | 152 | 59 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | 2.65e-04 | 1074 | 59 | 9 | C0006142 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 3.62e-04 | 69 | 59 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | T-Cell Lymphoma | 4.63e-04 | 16 | 59 | 2 | C0079772 | |
| Disease | Mammary Carcinoma, Human | 6.25e-04 | 525 | 59 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 6.25e-04 | 525 | 59 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 6.38e-04 | 527 | 59 | 6 | C1458155 | |
| Disease | Adenocarcinoma of lung (disorder) | 7.78e-04 | 206 | 59 | 4 | C0152013 | |
| Disease | Neurodevelopmental Disorders | 8.67e-04 | 93 | 59 | 3 | C1535926 | |
| Disease | progranulin measurement | 8.85e-04 | 22 | 59 | 2 | EFO_0004625 | |
| Disease | Renal glomerular disease | 9.68e-04 | 23 | 59 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 9.68e-04 | 23 | 59 | 2 | C4521256 | |
| Disease | triacylglycerol 56:4 measurement | 1.05e-03 | 24 | 59 | 2 | EFO_0010431 | |
| Disease | Prostatic Neoplasms | 1.42e-03 | 616 | 59 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.42e-03 | 616 | 59 | 6 | C0376358 | |
| Disease | spontaneous coronary artery dissection | 1.76e-03 | 31 | 59 | 2 | EFO_0010820 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IMPNQVMNGSIGAGR | 186 | Q09472 | |
| VMNGSIGAGRGRQNM | 191 | Q09472 | |
| ISSGRSTPAMMNGQG | 236 | Q6ZN18 | |
| QAMSRGTMIVGAATG | 266 | Q9BQE5 | |
| MSVGMGQPPAQTGVS | 806 | Q92793 | |
| GQMTPMQGGRSSTIS | 1291 | Q8NFD5 | |
| MQGVRMGGTPTNVAT | 1841 | Q9NYQ6 | |
| GSGPVSMERGQVPMQ | 286 | P33240 | |
| QGSRQVPVMQGTGMQ | 496 | P33240 | |
| VPVMQGTGMQGASIQ | 501 | P33240 | |
| AGQMTPAGQMTPAGV | 451 | Q6IQ32 | |
| GVRMTAMGSSPNIAS | 101 | Q8IUD2 | |
| SMSQPIMVQRRSGQG | 56 | Q8TB72 | |
| QTVMPGQVMRVTTGA | 401 | Q9NQX3 | |
| SSNPMDGMDNRTVGG | 511 | Q6P3S6 | |
| VIPNGSMAMGTVPGQ | 256 | Q5XG99 | |
| AAPRTNGVAMGMVAG | 186 | Q92567 | |
| MGIGPSQNPGTMATA | 836 | Q96JK9 | |
| GQQGTSQARPMVMSG | 1036 | Q96JK9 | |
| SQARPMVMSGLSQGV | 1041 | Q96JK9 | |
| GMVIMRSGQPLTGTN | 196 | Q96QG7 | |
| VRMVVGAAGGTQITM | 121 | Q9BX51 | |
| TMMGRQEPGQQGIVP | 106 | O43896 | |
| MTMAGGRRGLVAPQN | 1 | O95259 | |
| MGEPQGSMRILVTGG | 1 | Q13630 | |
| MMLSGQVPFQGASGQ | 601 | O75676 | |
| STGRGRGMVEMIPNA | 1121 | O00750 | |
| TALSPSGMGAMGAQQ | 106 | P55317 | |
| GQGQGPRAEAMMRSS | 3706 | Q9P2D7 | |
| AMVVTGLGGNPMAVV | 331 | O60341 | |
| TGNMGIPGTMNQISP | 151 | Q7Z5Q1 | |
| DLTISINQMGSPGMG | 916 | Q86UU0 | |
| MMATGTPESQARFGQ | 1 | Q96B45 | |
| RMTSGRSGVGVAVTM | 596 | Q14145 | |
| MFGIQENIPRGGTTM | 1 | Q9H4W6 | |
| TGMGGMVQTVQTRYT | 156 | P56856 | |
| ASLRTGPMVQGRGIM | 306 | Q53GL7 | |
| GPMVQGRGIMTTGSG | 311 | Q53GL7 | |
| GSLGQAEQVSSMPMG | 341 | Q53GL7 | |
| PVVGIMATGGGARAM | 321 | Q86XP0 | |
| TGGCMVDMQVVRNGT | 136 | O14994 | |
| MPRGMQGTSLGQVSF | 331 | Q6UX01 | |
| SGMVPMTGFTQRATI | 506 | Q9UL63 | |
| GEAGGSTPNTVTMEM | 321 | Q96AM1 | |
| MEGMTNGVAVGQQPS | 546 | P22670 | |
| LMSPTGGRMSVFQTQ | 626 | O95486 | |
| AATAPVGINMRSGMQ | 1081 | Q15788 | |
| RNSMVSRGMTGNIGG | 1201 | Q15788 | |
| MSQPMGVVPGTANTS | 2286 | O75376 | |
| GGVQSVMGSRLGQMV | 171 | O60664 | |
| MRQSGGSQPSMRQVG | 386 | Q86VE3 | |
| RGISISPSAGQMQMQ | 831 | Q9Y2K2 | |
| PQGSPTMGSSVMGTQ | 871 | Q6P3W7 | |
| MQGVPRGSSMGVRNS | 951 | Q7L7X3 | |
| NIQGMTGTPMVAASP | 256 | P61371 | |
| QTQMVSDGMTGSNPV | 16 | Q6ZRS2 | |
| VPMSTAGQTSRGVTM | 516 | Q7Z6J0 | |
| VGQVAIPMTGMINGN | 131 | Q5TBC7 | |
| GMAGQVPPLQSVTMG | 336 | O95081 | |
| GMNHVSGMQATTPQG | 446 | Q15596 | |
| AATTSAMNRPVQGGM | 966 | Q15596 | |
| MRVGPVRSAMSGASQ | 1 | Q96RU8 | |
| PMVSALNIRVGGTGM | 441 | P07911 | |
| AGMMGGGEAPQVTAS | 146 | A0A1B0GUW6 | |
| MPSLVVSGIMERNGG | 1 | A1L020 | |
| GVGASMFNTPGMQSL | 366 | Q9UMX0 | |
| SGQEMTAVMQSGRPR | 141 | O94876 | |
| QGLRQAPLASGMMTG | 11 | Q495A1 | |
| GSINGITFQGVPMVM | 256 | Q8NAM6 | |
| QSSRTMVVMGGVSGQ | 21 | Q9UQR1 | |
| MVVMGGVSGQSTVSG | 26 | Q9UQR1 |